NEW YORK (GenomeWeb) – Agilent Technologies today announced the completion of its acquisition of Seahorse Bioscience.

Agilent said in a statement that Seahorse's technology for measuring cell metabolism and bioenergetics complements Agilent's separations and mass spectrometry business. The approximately 200 Seahorse employees are now a part of the Mass Spectrometry Division of the Life Sciences and Applied Markets Group.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.